Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images at an imaging core lab (ICON Medical Imaging, Warrington, PA, USA). A binary qualitative scale (amyloid positive: Aβ+ or amyloid negative: Aβ−) was implemented in this study according to the pattern of tracer uptake observed in cortical gray matter areas. The PET rating methods, visual rater training and reliability have been described previously.22 (link),25 (link),27 (link) In brief, scans were rated as amyloid negative if tracer retention was seen predominantly in white matter, with no appreciable or low levels of tracer retention in cortical gray matter. Scans were rated as amyloid positive when tracer showed a gray matter pattern of distribution with accumulation along the midline and surface of the cortex.
PET Amyloid Imaging Protocol Qualification
Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images at an imaging core lab (ICON Medical Imaging, Warrington, PA, USA). A binary qualitative scale (amyloid positive: Aβ+ or amyloid negative: Aβ−) was implemented in this study according to the pattern of tracer uptake observed in cortical gray matter areas. The PET rating methods, visual rater training and reliability have been described previously.22 (link),25 (link),27 (link) In brief, scans were rated as amyloid negative if tracer retention was seen predominantly in white matter, with no appreciable or low levels of tracer retention in cortical gray matter. Scans were rated as amyloid positive when tracer showed a gray matter pattern of distribution with accumulation along the midline and surface of the cortex.
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Duke Medical Center, Massachusetts General Hospital, Harvard University, Banner Sun Health Research Institute, Nova Southeastern University, University of California, San Diego
Variable analysis
- Site PET scanners used (Discovery LS PET/CT, Advance PET, ECAT HR+, Biograph PET/CT)
- Intravenous injection of 10 mCi (370 MBq) of florbetapir F 18
- Emission scan (10-min, acquired in 2 × 5 min frames) after intravenous injection of florbetapir F 18
- Binary qualitative scale (amyloid positive: Aβ+ or amyloid negative: Aβ−) based on the pattern of tracer uptake observed in cortical gray matter areas
- Hoffman brain phantom used to qualify site PET scanners
- Image reconstruction utilizing an iterative algorithm (4 iterations, 16 subsets) and a post reconstruction Gaussian filter of 5 mm
- Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images at an imaging core lab (ICON Medical Imaging, Warrington, PA, USA)
- Hoffman brain phantom used to qualify site PET scanners
- Three nuclear medicine physicians, blinded to clinical data, independently rated the PET images
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!